Table 3.
Model 1 |
Model 2 |
Model 3 |
||||
---|---|---|---|---|---|---|
beta (95% CI) | P-trend | beta (95% CI) | P-trend | beta (95% CI) | P-trend | |
NSED Q5 (most disadvantaged) | ||||||
Q4 (most disadvantaged) | 0.72 (0.67–0.77) | <0.001 | 0.81 (0.76–0.87) | <0.001 | 0.79 (0.74–0.85) | <0.001 |
Q3 | 0.42 (0.37–0.48) | 0.46 (0.40–0.51) | 0.44 (0.39–0.50) | |||
Q2 | 0.30 (0.23–0.36) | 0.33 (0.27–0.39) | 0.32 (0.26–0.38) | |||
Q1 (least disadvantaged) | ref | Ref | ref | |||
NSED Q4 | ||||||
Q4 (most disadvantaged) | 0.62 (0.57–0.67) | <0.001 | 0.71 (0.66–0.76) | <0.001 | 0.68 (0.64–0.73) | <0.001 |
Q3 | 0.37 (0.32–0.42) | 0.41 (0.35–0.46) | 0.39 (0.34–0.44) | |||
Q2 | 0.25 (0.19–0.31) | 0.28 (0.22–0.33) | 0.27 (0.21–0.32) | |||
Q1 (least disadvantaged) | ref | Ref | ref | |||
NSED Q3 | ||||||
Q4 (most disadvantaged) | 0.55 (0.51–0.60) | <0.001 | 0.65 (0.60–0.70) | <0.001 | 0.61 (0.57–0.66) | <0.001 |
Q3 | 0.30 (0.26–0.35) | 0.33 (0.28–0.38) | 0.31 (0.26–0.36) | |||
Q2 | 0.25 (0.20–0.31) | 0.28 (0.23–0.33) | 0.26 (0.21–0.32) | |||
Q1 (least disadvantaged) | ref | Ref | ref | |||
NSED Q2 | ||||||
Q4 (most disadvantaged) | 0.55 (0.51–0.59) | <0.001 | 0.64 (0.60–0.69) | <0.001 | 0.62 (0.57–0.66) | <0.001 |
Q3 | 0.32 (0.27–0.36) | 0.35 (0.31–0.39) | 0.33 (0.29–0.38) | |||
Q2 | 0.24 (0.19–0.29) | 0.27 (0.22–0.32) | 0.26 (0.21–0.21) | |||
Q1 (least disadvantaged) | ref | Ref | ref | |||
NSED Q1 (least disadvantaged) | ||||||
Q4 (most disadvantaged) | 0.50 (0.46–0.55) | <0.001 | 0.58 (0.54–0.63) | <0.001 | 0.55 (0.50–0.59) | <0.001 |
Q3 | 0.29 (0.25–0.33) | 0.33 (0.28–0.37) | 0.30 (0.26–0.34) | |||
Q2 | 0.28 (0.24–0.32) | 0.31 (0.27–0.36) | 0.30 (0.26–0.34) | |||
Q1 (least disadvantaged) | ref | Ref | ref |
Model 1: ISED; Model 2: Model 1+ age+ sex; Model 3: Model 2+ body mass index (BMI).